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Introduction
Burkholderia pseudomallei (Bp) and Burkholderia mal-
lei (Bm), the etiologic agents of melioidosis and glanders, 
respectively, are classified as Tier 1 bacterial select agents. 
Bm is an obligate animal pathogen which causes a debilitat-
ing and often fatal zoonotic disease of equines. It has been 
eradicated in most countries, but is still found in parts of 
Africa, the Middle East, Eastern Europe, Asia, and South 
America. In contrast, Bp is a saprophytic, free-living organ-
ism which causes endemic infections in tropical regions 
such as Southeast Asia and Northern Australia. Both agents 
can infect humans and animals by several routes. Infections 
occur upon exposure to contaminated water, soil, or secre-
tions, and through skin abrasions, inhalation, or ingestion. 
The diseases are manifested by protean, often nonspecific 
generalized symptoms such as fever and malaise, ulcerat-
ing lesions of the skin and mucus membranes, pneumo-
nia, granulomatous abscesses in multiple organs, and sep-
ticemia. Without effective treatment, the course of these 
diseases may range from acute and rapidly fatal to a very 
protracted and frequently chronic form, as described below 
(Dance 2014; Gregory and Waag 2008; Welkos et al. 2015; 
Wiersinga et al. 2012).
These pathogens are global concerns for several rea-
sons including the wide environmental range of Bp, the 
challenges posed in diagnosing the diseases and identify-
ing the agents, treatment complications due to inherent and 
acquired antibiotic resistance, and their potential for adver-
sarial use (Currie et al. 2000, 2010; Dance 2014; Dance 
et al. 1991; Fritz and Waag 2012; Naha et al. 2012, 2014; 
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Vidyalakshmi et al. 2008; Wiersinga et al. 2012). In addi-
tion, these pathogens are potential biothreat agents because 
of their high aerosol infectivity and ability to cause severe 
disease with often nonspecific symptoms (Fritz and Waag 
2012; Wiersinga et al. 2012).
These highly pathogenic Burkholderia species are capa-
ble of eliciting a wide range of infection states, i.e., acute, 
chronic, recurrent and latent (Currie et al. 2000; Nigg 1963; 
Tarlow and Lloyd 1971). Acute infection can manifest as 
a severe fulminant disease with overwhelming septicemia 
and pneumonia. Chronic forms are characterized as per-
sistent infections which recrudesce clinically at varying 
intervals. They are characterized by signs and symptoms 
similar to, but milder than, those of the acute disease. These 
chronic infections are commonly associated with immuno-
compromising conditions, e.g., diabetes, and can persist for 
years. Reoccurring illness is also observed and can poten-
tially be due to reinfection or relapse of a persistent infec-
tion. Latent infections are asymptomatic and can remain 
subclinical or alternately progress to acute melioidosis up 
to decades after the initial exposure. All of these forms, 
especially the more persistent ones, can be very challeng-
ing to diagnose and treat effectively (Dance 2014; Fritz and 
Waag 2012; Wiersinga et al. 2012).
To prevent the conversion of an active primary infection 
into a chronic or subclinical form, it is necessary to identify 
bacterial and host phenotypic changes which might mark 
infection transition to a long-term persistent state. The 
purpose of this study was to develop a scheme to identify 
in vitro bacterial phenotypes potentially associated with 
persistent infection and determine its capacity to distin-
guish isolates which persist in chronically or subclinically 
infected mice. These objectives are based on the hypothesis 
that the transition of an infection from an acute to persis-
tent, long-term form involves adaptive changes in bacteria 
facilitating their resistance to antibacterial host responses. 
This hypothesis is supported by numerous studies on Bp 
and other Gram-negative bacteria and their ability to adapt 
to, or persist in, harsh environments and stressful host con-
ditions. Previous studies documented resistance to extended 
periods of anaerobiosis, pH extremes, phagolysosomal con-
tents such as antimicrobial peptides, antibiotics, and other 
stressors (Butt et al. 2014; Chen et al. 2014; Fauvart et al. 
2011; Goodyear et al. 2012; Hamad et al. 2011; Hayden 
et al. 2012; Keren et al. 2004; Kint et al. 2012; Price et al. 
2013; Pumpuang et al. 2011; Romero et al. 2006) and 
attempted to identify reliable in vitro markers for long-term 
colonization or chronic infection (Chantratita et al. 2007, 
2012; Chen et al. 2014; Hayden et al. 2012; Tandhavanant 
et al. 2010; Velapatino et al. 2012). Phenotypic switching, 
as manifested typically by colony morphology variation, is 
a well-known phenomenon in the highly pathogenic Bur-
kholderia. In 1924, Stanton and Fletcher first reported the 
presence of two colony morphotypes, a rough and mucoid 
form, isolated from a patient infected with Bp (previously 
Bacillus whitmori) (Stanton et al. 1924). Nicholls and Can-
tab (1930) isolated and characterized similar variants of 
B. whitmori from abscess material from an infected cow. 
The morphotypes were reversible, with the rough being 
more abundant and stable than the mucoid type. The colony 
types were associated with in vitro phenotypic differences 
such as production of alkaline conditions in broth, and evi-
dence suggesting differences in virulence was described. 
Numerous more recent studies have supported the hypoth-
esis that different colony morphotypes potentially reflect 
adaptive changes that enhance fitness in a particular envi-
ronment (Austin et al. 2015; Chantratita et al. 2007; Rogul 
and Carr 1972; Tandhavanant et al. 2010; Velapatino et al. 
2012; Wikraiphat et al. 2015; Shea, A., unpublished).
In this study, a panel of phenotyping tests for differenti-
ating splenic mouse isolates of Bp and Bm was developed 
in efforts to identify markers for distinguishing isolates 
responsible for persistent infection. The tests included 
colony morphology differentiation, chemical and peptide 
sensitivity, macrophage infection and cytotoxicity, and LPS 
characterization. The goal was to identify markers which 
could then be further investigated to determine how Burk-
holderia transitions from an acute to chronic infection.
Materials and methods
Bacterial strains, media, and chemicals
The strains of Bp and Bm and their sources are described in 
Supplementary Table 1. Bm strains Turkey 1 and 10229 and 
Bp strains 316c and 4845 were obtained from the USAM-
RIID Therapeutics Core (TC) group. The Bm strain used 
as the prototype was Bm FMH, a relatively recent human 
clinical isolate derived from strain Bm ATCC 23344/China 
7. This strain, Bp prototype strains K96243 and 1026b, 
and the remaining seven Bp strains described in the table 
were obtained from the USAMRIID Unified Culture Col-
lection (UCC). All the Burkholderia strains were human 
clinical isolates with the exception of Bp 4845 and possi-
bly Bm Turkey 1. Two of the three Bm strains were viru-
lent in the hamster model of glanders (D. DeShazer, unpub-
lished data). Additional stocks of Bm strain ATCC 23344/
China 7 and Bp strain K96243 were obtained from fellow 
investigators [gifts from D. Waag (DW) and D. DeShazer 
(DD)] and used where indicated in the text. Plated media 
were available commercially (Thermo Fisher-Remel, 
Lenexa, KS) as described below, or prepared in-house. 
The differential/nonselective media included sheep blood 
agar (SBA) plates and glycerol tryptone agar (GTA). 
The four differential/selective media used were: OFPBL 
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(oxidation–fermentation base polymyxin B–bacitracin–lac-
tose) agar plates; PC/BCA (Pseudomonas/Burkholderia 
cepacia agar) plates with polymyxin B, ticarcillin, and 
dye to detect alkaline pyruvate metabolism; BCSA (Burk-
holderia cepacia selective agar) plates with polymyxin B, 
gentamicin, vancomycin, sucrose, and lactose with dye to 
detect acid production (for Bp); and Ashdown’s agar (AA) 
plates containing dyes and gentamicin (for Bp) or no anti-
biotic (for Bm). All were available commercially (Thermo 
Fisher-Remel) except GTA and AA plates which were 
manually prepared (Ashdown 1979; Fritz et al. 2000). 
Liquid growth media were glycerol tryptone broth (GTB) 
(Fritz et al. 2000) and cation-adjusted Mueller–Hinton 
broth (MHB) (BBL™, BD Diagnostics Franklin Lake, NJ). 
Chemicals were obtained from Sigma-Aldrich (St. Louis, 
MO), and antimicrobial peptides were acquired from the 
following sources: Sigma/Fluka, Bachem (Torrance, CA), 
Biopeptek (Malvern, PA), Synthetic Biomolecules (San 
Diego, CA), and Peptides International (Louisville, KY).
Chemical sensitivity and enzyme production
Three platforms are used for sensitivity testing and enzyme 
detection: (1) GEN III MicroPlates™ (Biolog, Inc., Hay-
ward, CA) which include 23 antimicrobial chemicals for 
screening sensitivity/growth inhibition; (2) agar plate 
assays for assessing sensitivity to hydrogen peroxide (rep-
resentative of reactive oxygen species) and for detect-
ing protease production using skim milk agar plates, as 
described (Sokol et al. 1979); and (3) microtiter tests to 
evaluate sensitivity to selected chemicals and antimicrobial 
peptides (AMPs) in which growth or inhibition was deter-
mined by measuring optical density (OD630).
The GEN III plates were inoculated as described by the 
manufacturer. After incubation for 48 h (Bp) or 72 h (Bm), 
growth was detected by measuring OD630. The data were 
scored in accordance with the Biolog instructions: Wells 
with growth similar to the plate positive control well were 
scored resistant (R), well readings less than half the posi-
tive control were sensitive (S), and readings which were 
borderline (±0.1 OD630 units below or above the R or S 
cutoffs) or variable were scored as R/S.
Chemicals selected for testing in the microtiter assays 
included NaCl (1, 4, and 8 %), nalidixic acid (5 and 50 µg/
mL), surfactant Niaproof 4 (0.027 and 0.10 %), reac-
tive oxygen species (ROS) inducer paraquat dichloride 
(2.5 µM), and reactive N2 intermediate (RNI) sodium nitrite 
(2 mM). The Bm and Bp strains were differentially respon-
sive to the selected concentrations in preliminary tests; both 
were sensitive to 2 mM sodium nitrite as shown previously 
(Tandhavanant et al. 2010); and Bp strains were generally 
sensitive to 2.5 µM paraquat similarly to Escherichia coli 
(Cho et al. 2012). Twelve antimicrobial peptides (AMPs) 
were screened: cecropin A and P1, mastoparan 7, LL-37, 
magainin, histatin 5, melittin, HNP-1, hBD-2, BMAP-18, 
bactenecin, and CA-MA (Fox et al. 2012; Kanthawong 
et al. 2009; Madhongsa et al. 2013; Tandhavanant et al. 
2010). Four AMPs (cecropin A, mastoparan 7, magainin, 
and melittin) were downselected for testing with all strains 
since they exhibited greatest antibacterial activity for the 
Burkholderia. Some strains were tested with an additional 
four because of differential sensitivity (LL-37, BMAP-18, 
bactenecin, and CA-MA). Due to the generally high level 
of resistance, a single concentration of each AMP was 
tested (200 µM for cecropin A and magainin and 100 µM 
for the rest due to reduced solubility in liquid media MHB 
and GTB) (Kanthawong et al. 2009; Tandhavanant et al. 
2010). E. coli strains ATCC 25922 and Bp K96243 were 
used in the assays to verify activity. After addition of the 
antimicrobials to the trays, the wells were inoculated 
with strains adjusted to a concentration of approximately 
1 × 106 CFU/mL in MHB (Bp) or GTB (Bm). The trays 
were incubated and read as described for the Biolog trays, 
and the absorbance results were recorded as resistant (R, 
OD630 >75 % positive growth control); sensitive (S, OD630 
<50 % positive control); borderline (R/S, OD630 >50 % and 
<75 % positive control); or very sensitive (S+, OD630 ≤2× 
the uninoculated negative control wells containing medium 
alone).
A separate assay for sensitivity to a combination of 
the enzymes lactoferrin and lysozyme (20 and 200 µg/
mL, respectively), or each alone, was also conducted as 
described previously (Ellison and Giehl 1991; Tandha-
vanant et al. 2010). Microtiter plates containing PBS alone 
or PBS with lactoferrin, lysozyme, or lactoferrin plus 
lysozyme were inoculated with bacterial suspensions, and 
the plates were incubated for 48 h at 37 °C. The effect of 
the enzymes on growth was detected by measuring optical 
density (OD630) and by comparison of the densities of the 
treated wells to that of the untreated well (PBS alone).
Characterization of Burkholderia survival 
and cytotoxicity in macrophages
Phagocytosis assays were developed to measure the abil-
ity of Bp and Bm to infect macrophages and to induce cell 
damage. The ability of the strains to replicate inside mac-
rophages was also determined by plating for viable counts 
at various time points post-phagocytosis. The procedure 
was similar to those described previously (Arjcharoen et al. 
2007; Burtnick et al. 2011; Kespichayawattana et al. 2000; 
Mulye et al. 2014; Tandhavanant et al. 2010; Welkos et al. 
2015). The J774.A1 murine-derived macrophage-like cell 
line was cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) with glucose, glutamine, and 10 % fetal bovine 
serum in 24-well plates (with or without coverslips). The 
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cells were incubated for 2 days at 37 °C with 5 % CO2, at 
which time growth to 90–95 % confluence was achieved. 
On the day before the experiment, glycerol tryptone broth 
(GTB) was inoculated with growth from fresh SBA plate 
cultures of the bacteria and the flasks were incubated 
overnight at 37 °C with shaking at 200 rpm. Optical den-
sity measurements of the cultures were taken, suspensions 
adjusted to OD620 of 1.0 (~1×109/mL) were prepared, and 
the macrophages were inoculated with Burkholderia at a 
target multiplicity of infection (MOI) of 5–10 bacteria per 
macrophage for Bm and <5 or 20 bacteria per macrophage 
for Bp. The infected macrophages were then incubated at 
37 °C for 1 h to allow bacterial phagocytosis. The cells 
were washed three times to remove unphagocytosed bac-
teria, and fresh medium was added which contained 250–
500 µg/mL of kanamycin to inactivate any residual extra-
cellular bacteria. The cells were incubated for an additional 
2 h, washed to remove the kanamycin, and then either 
lysed to determine the extent of phagocytosis or refed 
with medium containing 20 µg/mL of kanamycin. The lat-
ter cultures were then incubated for a total of 7–8 h (Bp) 
or 20–22 h (Bm) to determine the level of replication and 
cytotoxicity. The incubation times were determined based 
on differences in growth and infection rate. As will be 
described below, the shorter incubation times for Bp facili-
tated detection of variations in the responses of different 
strains. Bp strains generally grew and killed the cells more 
rapidly than Bm causing excessive cell loss when incubated 
for the time used in the Bm assays. The lysed macrophage 
samples were diluted and plated on SBA plates to deter-
mine quantitative viable counts of the intracellular bacteria. 
To account for differences in strain MOIs, the viable CFU 
counts were also normalized to the inoculum and expressed 
as percentages. In separate wells, the extent of cell cytotox-
icity was measured by trypan blue (TB) dye uptake and/or 
by staining with propidium iodide (PI). Live cells exclude 
TB and PI and are unstained under phase (TB) or fluores-
cence (PI) microscopy, whereas dead cells are permeable 
and have blue (TB) or bright red (PI)-stained nuclei. Cells 
on coverslips were alternately stained with Diff-Quik™ 
histologic stain to assess macrophage condition (normal 
versus necrotic, apoptotic, or multi-nucleated appearance 
of cells and nuclei), extent of formation of multi-nucleated 
giant cells (MNGCs), and the relative level of residual 
bacterial infection. It should be noted that the nuclei in 
advanced-stage MNGCs are often necrotic, poorly visible, 
and no longer stainable by PI or TB; however, they were 
detectable by Diff-Quik™ stain.
Based on studies with different strains, the follow-
ing phenotypes were developed for the initial screen-
ing of strains and in vivo isolates of Burkholderia: (1) 
relative bacterial survival, as determined by viable plate 
counts of lysed cells harvested at 6–8 h (Bp) or 20–22 h 
(Bm) post-phagocytosis in comparison to the concentra-
tion of bacteria present in the inoculum; (2) cytotoxicity, 
as assessed by live–dead staining with TB and PI to esti-
mate the proportion of dead cells and determine the per-
centage of cells lost compared to the uninfected monolayer 
in a low power field (100× final magnification), and by 
staining to detect morphologic changes (Diff-Quik™); 
and (3) MNGC, as determined by the relative proportion 
of MNGCs compared to normal cells and by the nuclear 
morphologies (% nuclei contained in MNGCs of the total 
nuclei present in a higher power field [600× final magni-
fication]). For the microscopy data, cells in a minimum of 
six separate fields, two for each of three Diff-Quik-stained 
coverslips were counted to obtain the MNGC parameters 
and to compare the extent of cell loss; three fields in dupli-
cate TB- or PI-stained wells were examined to determine 
the proportion of dead cells and estimate of percentage cell 
loss. Strains selected for further analysis as a result of the 
screening were evaluated in assays which measured bac-
terial adherence and extent of uptake, as well as the time 
course of intracellular viability. Infected macrophage sam-
ples were lysed and diluted/plated immediately after the 
1-h phagocytosis period, at the 3-h time point (after 2-h 
incubation in antibiotic), and after incubation of infected 
cells for a total of 8 h (Bp) or 20–22 h (Bm).
LPS characterization
Differences in the gel banding profiles of LPS from differ-
ent strains or spleen isolates of Bm and Bp were examined 
using silver-stained 10–20 % tricine gels and western blots 
probed with various Bm- and Bp-specific monoclonal and 
polyclonal antibodies, by methods described previously 
(Welkos et al. 2015). Silver staining was conducted using 
the method described by Tsai and Frasch (1982).
Animal challenges
BALB/c mice (female, 7–10 weeks of age at time of chal-
lenge) were obtained from the National Cancer Institute, 
NCI/Charles River (Frederick, MD), and used in groups of 
10 for challenge by aerosol or intraperitoneal (IP) routes as 
part of LD50 determinations and prospective serial collec-
tion experiments. IP challenges were conducted with vari-
ous doses of Bp or Bm grown in GTB, as described previ-
ously (Welkos et al. 2015). The bacteria were quantified 
via OD620 estimations and delivered IP in 200 µL of GTB. 
The delivered doses were then verified by plate counts on 
SBA. The animals were monitored for clinical signs and 
symptoms for 60 days, except where indicated below. Early 
endpoint euthanasia was uniformly employed to limit pain 
and distress (Welkos et al. 2015). Aerosol challenges were 
done by whole-body exposure to aerosols generated by 
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nebulization of GTB-diluted overnight cultures in a modi-
fied Henderson apparatus, as described previously (Jed-
deloh et al. 2003; Waag and DeShazer 2004).
Bacterial isolates were obtained from mice surviving 
challenge by the aerosol or IP routes; spleens collected 
from mice euthanized at various times after challenge were 
homogenized and cultured on SBA plates for recovery of 
viable Burkholderia, as described previously (Amemiya 
et al. 2015).
Research was conducted under an IACUC-approved 
protocol in compliance with the Animal Welfare Act and 
other federal statutes and regulations relating to animals 
and experiments involving animals and adheres to the prin-
ciples stated in the Guide for the Care and Use of Labora-
tory Animals, National Research Council, 2011. The facil-
ity where this research was conducted is fully accredited by 
the Association for Assessment and Accreditation of Labo-
ratory Animal Care International.
Statistical analysis
Differences in the viable counts obtained from infected 
macrophages were determined by t test or, when more than 
two strains were compared, by ANOVA and Tukey multi-
comparison post-tests. The mean OD630 values determined 
from replicate GEN III microtiter plate experiments were 
evaluated for sensitivity compared to the growth control by 
ANOVA and multi-comparison post-tests. These statistical 
analyses were done with GraphPad Prism versions 5.2 and 
6.0. The day 21 and 60 survival data of mice challenged by 
IP route with Burkholderia were analyzed for each strain, 
and the data were evaluated statistically to compare parent 
strain and spleen derivative virulence potencies. Bayesian 
probit analysis was used to calculate median lethal dose 
(LD50) and 95 % credible interval estimates and to con-
struct dose response curves. The statistical analyses were 
performed using Stan 2.1.0 and R.3.1.1 software (SD Team 
2013, 2014; Welkos et al. 2015).
Results
Characterization of a phenotyping panel 
for Burkholderia strains
The development and evaluation of assays to be used for 
phenotyping animal isolates were conducted using strains 
that were designated as “prototypes.” For Bm, the chosen 
strain was Bm ATCC 23344/China 7 and a derivative  iso-
lated from a relatively recent case of human glanders, FMH 
(Srinivasan et al. 2001 and Supplementary Table 1). Strains 
K96243 and 1026b were designated as the Bp prototypes. 
These strains have all been described extensively in the 
literature, have been sequenced, and are considered to be 
representative of typical virulent strains of Burkholderia. 
As a result, they are frequently employed in animal models. 
First, the phenotypes of the prototypes were compared to 
that of other strains of the same species. Bm strains ATCC 
23344/China 7, FMH, Turkey 1, and 10229 were screened 
in the initial phenotyping stages. Besides the Bp prototype 
strains, Bp strains 316c, 4845, Bp22, and MSHR5855 were 
also examined initially.
Colony morphotyping
To characterize colony morphology of Bp and Bm, six 
selective and/or differential media were used: SBA, 
GTA, AA, OFPBL, BCA, and BCSA. In addition, skim 
milk agar was included to assay for protease production. 
Because Bm strains are susceptible to gentamicin, a modi-
fied version of Ashdown’s medium lacking the antibiotic 
was used for Bm strains. The use of six media allowed 
strains to be differentiated morphologically in at least 
seven characteristics, i.e., colony size, color, moistness, 
opacity, circumference shape, surface texture, and changes 
in agar color (the extent of hemolysis activity on SBA 
plates or change in indicator color due to bacterial meta-
bolic activity, e.g., acid production). Colony phenotyping 
for Bp strains is illustrated in Fig. 1. Whereas a variety of 
different randomly occurring phenotypes were readily dis-
tinguished among the Bp strains, the strains of Bm exhib-
ited few morphological differences (data not shown). The 
variable production of different colony morphotypes often 
observed for Bp strains was especially apparent using 
SBA, GTA, and AA. The variant colonies demonstrated on 
the SBA plate (Fig. 1a) are those of Bp strain MSHR668; 
strain K96243 was used to illustrate growth by Bp on 
OFPBL, AA, BCA and BCSA selective media, respec-
tively (Fig. 1b–e). Despite the random morphotypic heter-
ogeneity often observed in Bp strains, the flat, rough colo-
nies which appear in the majority on the AA plate (Fig. 1c) 
illustrated one of the morphotypes commonly observed on 
AA plates among the Bp strains studied here. Specifically, 
this morphotype was a relatively flat, rough, often dry, and 
striated colony type, which was observed for many strains, 
albeit in varying relative abundance. Similar morphotypes 
were among those described previously by Chantratita 
et al. (2007) in a set of seven morphotypes (I–VII). The 
colonies we observed in the Bp parent strains varied in 
color and central colony texture but resembled variants of 
Morphotype I (rough colony center) or IV (striated, with 
smooth umbonated center), and had a purple color ranging 
from light to dark, as described for Morphotypes I or IV 
and Morphotype II, respectively. The colonies exhibited 
differences between plating on AA in color, moisture, and 
surface texture, as illustrated by the 406e parent strain in 
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Supplementary Table 5A and B. However, this flat, rough 
colony type and variants thereof may represent the major 
colony phenotype isolated from patients with melioido-
sis and the colony from which switching to other colony 
morphotypes occurred in vivo, as reported by Chantratita 
et al. (2007). In addition to AA plates, this morphotype 
was characterized by relatively flat, nonmucoid colonies 
on SBA plates, as described previously (Wikraiphat et al. 
2015), and by acid production on OPFBL plates. A form 
similar to this flat, rough morphotype was produced in var-
ying proportions by all of the six strains described below 
in the mouse isolate studies (K96243, 1026b, 1106a, 
406e, MSHR305, and HBPUB10134a) and by Bp22, 
MSHR5855, 316c, and 4845.
Fig. 1  Colony morphology of Bp strains on selective/differential 
media. a The growth of Bp strain MSHR668 on SBA plates illustrates 
the colony morphology variation that is commonly observed for Bp. 
On this plate, three colony types are shown: the majority of the colo-
nies are small, round, and smooth (#1); the next most numerous are 
larger, shinier, and less opaque, and have a translucent edge (#2); and 
there are two “water splat” colonies that are large, flat, and translu-
cent/clear, and have an irregular edge (#3). The growth of Bp strain 
K96243 illustrates morphologies produced by Bp on several selective 
media (b–e). b OFPBL plate. c AA plate showing a common colony 
morphology of Bp strains. d BCA plate. Strains metabolizing the 
peptones and pyruvate produce alkaline conditions changing the agar 
indicator color from orange to pink. e BCSA plate, used for Bp only. 
This medium distinguishes strains which metabolize the peptones 
(alkaline color change) or catabolize the carbohydrates (acidic color 
change from deep pink to yellow, as shown for K96243)
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Chemical sensitivity testing and enzyme production
Chemical sensitivity tests in the Biolog GEN III panel were 
evaluated as a candidate phenotyping tool. Several strains 
of Bm and Bp were used to determine optimal incubation 
times, assess the range of responses, and establish the scor-
ing. The responses of prototype strains Bm ATCC 23344/
China 7 and Bp K96243 were compared, and the results 
indicated that Bp is potentially more resistant to potential 
environmental, intra-phagocyte, and antimicrobial stresses 
than Bm (Supplementary Table 2). Bm and Bp were simi-
larly resistant to some antibiotics (rifampin, lincomycin, 
and vancomycin), and Bp was more resistant than Bm 
to other antibiotics (troleandomycin, nalidixic acid, and 
minocycline). Both species exhibited a similar sensitivity 
to NaCl concentrations (variable growth in 1 % but not 4 
or 8 %) and were fully resistant to mild pH stress (pH 6). 
Bm was moderately resistant, while Bp was fully resistant 
to low pH stress (pH 5). Bp K96243 was more resistant to 
potassium tellurite and to the surfactant Niaproof 4 than 
Bm ATCC 23344/China 7.
Further studies were done with additional Burkholde-
ria strains. Bm strain ATCC 23344/China 7 did not show 
any differences associated with the source of the strain 
(different culture collections of the original or human iso-
late FMH), and there were few variations in sensitivity 
between Bm strain 23344 and the other two strains tested 
(Bm Turkey 1 and 10229) (data not shown). In assays with 
10 strains of Bp (K96243, 1026b, 316c, 4845, MSHR668, 
1106a, 406e, HBPUB10134a, MSHR305, and Bp22), sev-
eral phenotypes exhibited strain-specific differences in sen-
sitivity, to include the antibiotics nalidixic acid, minocy-
cline, and aztreonam, as well as Niaproof 4 and potassium 
tellurite (Table 1). Inter-experimental variability in sensitiv-
ities to aztreonam, potassium tellurite, and Niaproof 4 was 
noted for some of the Bp strains and to a lesser extent for 
Table 1  Comparison of 
chemical sensitivities of 
different B. pseudomallei 
strains: Biolog phenotyping 
panel
The criteria for sensitivity are similar to those defined by Biolog, Inc.
Bold = growth densities (OD630) less than half that of positive control well are sensitive
Unchanged = growth densities similar to positive control are resistant
Bold italics = density compared to positive control is borderline or variable (different experiments or strain 
sources)
Chemical K96243/DW K96243/DD 1026b 316c 4845
Mean SD Mean SD Mean SD Mean SD Mean SD
Pos. ctrl. 1.644 0.141 1.558 0.019 1.706 0.064 1.719 0.140 1.567 0.256
1 % NaCl 1.279 0.153 1.492 0.015 1.540 0.138 1.673 0.002 1.380 0.016
Sodium lactate 1.841 0.167 1.737 0.027 1.820 0.082 1.826 0.025 1.669 0.191
Troleandomycin 1.356 0.309 1.280 0.068 1.406 0.296 1.332 0.511 1.253 0.443
Lincomycin 1.636 0.145 1.735 0.027 1.824 0.071 1.912 0.018 1.783 0.058
Vancomycin 1.730 0.181 1.692 0.083 1.826 0.077 1.795 0.134 1.729 0.063
Nalidixic acid 1.204 0.233 −0.097 0.009 −0.059 0.053 1.679 0.146 1.249 0.188
Aztreonam 0.097 0.040 0.647 0.312 0.237 0.106 0.318 0.170 0.253 0.332
pH 6 1.734 0.109 1.658 0.074 1.774 0.069 1.807 0.102 1.671 0.162
4 % NaCl −0.063 0.066 −0.121 0.010 0.026 0.089 0.052 0.218 −0.052 0.148
Fusidic acid 0.024 0.063 −0.117 0.000 −0.088 0.038 0.224 0.212 −0.060 0.121
Rifampin 1.667 0.187 1.617 0.121 1.809 0.042 1.847 0.188 1.725 0.173
Guanidine HCl 0.155 0.056 0.187 0.007 0.242 0.104 0.337 0.106 0.294 0.049
Tetrazolium violet 2.908 0.022 2.919 0.025 2.892 0.021 2.955 0.027 2.859 0.008
LiCl −0.022 0.151 −0.096 0.004 0.006 0.123 0.062 0.120 −0.038 0.142
Sodium butyrate 0.074 0.119 −0.098 0.002 0.050 0.096 0.197 0.145 −0.021 0.060
pH 5 1.828 0.152 1.769 0.066 1.837 0.062 1.692 0.254 1.797 0.126
8 % NaCl −0.141 0.015 −0.009 0.141 −0.113 0.024 −0.116 0.011 −0.149 0.007
d-Serine −0.072 0.028 −0.102 0.002 0.236 0.155 0.221 0.025 0.063 0.057
Minocycline 1.267 0.252 −0.098 0.012 −0.074 0.020 1.695 0.117 1.377 0.107
Niaproof 4 0.481 0.073 0.589 0.005 0.153 0.293 0.949 0.325 0.516 0.550
Tetrazolium blue 3.023 0.049 2.983 0.104 2.980 0.081 3.056 0.069 2.996 0.003
Potassium tellurite 0.877 0.971 1.605 0.010 1.002 0.970 1.291 0.787 1.645 0.046
Sodium bromate −0.121 0.017 −0.102 0.011 −0.101 0.016 −0.106 0.015 −0.136 0.008
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Bm strains. As described below, potentially confounding 
effects of this variability were alleviated in all phenotypic 
comparisons of in vivo isolates with the challenge strain by 
the inclusion of the parent strain in all in vitro assays.
In addition to the Biolog panel, Bm and Bp proto-
type strains were assayed independently for sensitivity to 
selected chemicals. Initial findings with Bm FMH and Bp 
K96243 indicated that both were sensitive to 2 mM sodium 
nitrite (RNI), as shown previously (Tandhavanant et al. 
2010). Also, Bm was more sensitive than Bp to H2O2, and 
both were similar in sensitivities to NaCl and Niaproof 4; 
Bp K96243 was more sensitive to these two chemicals in 
the individual assays than in the Biolog plates (Table 1, 
parent strains in Table 2 and Supplementary Tables 2 and 3, 
and data not shown). The concentrations of chemicals used 
in the Biolog microplate assays are proprietary and results 
can only be qualitatively compared to assays which use 
defined concentrations (B. Bochner, personal commun.). 
Responses of Bm and Bp were variable to 5 µg/mL nali-
dixic acid, but Bm strains were generally sensitive and Bp 
strains were generally resistant (parent strains in Table 2, 
Supplementary Tables 3 and 4, and data not shown). All 
strains were sensitive to 50 µg/mL nalidixic acid. Thus, 
the chemical sensitivity data indicated that Bp appeared 
to be generally more resistant to potential environmental 
and host antimicrobial stresses than Bm. Due to evidence 
of strain variability, the subsequent analyses of phenotypic 
changes in strains recovered during infection required that 
responses of the original parent strain be tested in each 
assay. The direct comparison of parent and in vivo isolates 
responses allowed relative differences to be detected.
The Burkholderia have been reported to be nota-
bly resistant to most AMPs at concentrations ≤200 µM. 
Although Bp has been shown to be sensitive in vitro to the 
peptide LL-37 (Kanthawong et al. 2009; Tandhavanant 
et al. 2010), we observed resistant to borderline resistant 
responses to LL-37 in repeated tests with Bm FMH and 
most Bp strains. These findings are exemplified for the par-
ent strain data in Table 2 and Supplementary Tables 3 and 
4. Sensitivities to five more AMPs were initially evaluated 
with the prototype strains. Bm and Bp were resistant to 
histatin 5, Bp was resistant more often than Bm to cecropin 
A and melittin, and both were often relatively sensitive to 
mastoparan 7 (data not shown). In skim milk agar assays 
for protease production, prototype strain Bp K96243 pro-
duced larger zones of clearing than Bm 23344/China 7, 
possibly due to the secretion of more protease by Bp and/or 
its faster rate of growth (data not shown). Since the Burk-
holderia demonstrated some variability in AMP sensitivity 
between experiments, the impact of this on later analyses 
of the sensitivities of infected mice isolates was mitigated 
by direct comparisons to the activity of the parent strain in 
each assay.
Macrophage phenotypes of the Bm and Bp strains
The J774.A1 cell line was used to develop several mac-
rophage phenotypes for comparing different strains of Bm 
and Bp. Several parameters were identified including rela-
tive bacterial survival over time within the macrophage 
and several infection-induced cytotoxic effects involving 
cell killing and MNGC production. In screening assays, 
the number of viable Bm recovered was much less than the 
number in the inoculum. In contrast, Bp prototype strain 
K96243 proliferated and exhibited a large increase in CFU 
compared to the input concentration, i.e., 600-fold after 
20 h (Fig. 2), but also after incubation for much shorter 
times, as described below. As shown in Fig. 2, for the Bm 
strains, there was a large decline in viable counts recovered 
20 h after infection (126-, 112-, and 267-fold, respectively, 
for FMH parent and isolates 1-1-3 and 1-2-4 from infected 
spleens). At t20, for all three Bm strains, <1 % of the input 
bacterial inoculum could be recovered (0.8, 0.9, and 0.4 %, 
respectively). In contrast, the Bp strain K96243 exhibited 
a 5.8-fold (581 %) increase in number of CFU/well at t20 
compared to the initial concentration added at t0. Despite 
the lower MOI of the K96243 inoculum (p < 0.8 × 10−5), 
the number of viable bacteria recovered at 20 h was signifi-
cantly greater than the viable organisms recovered of the 
Bm strains (p < 0.001 each, by ANOVA and Tukey post-
test paired comparisons). This pattern of survival and pro-
liferation in macrophages of K96243 was also observed 
for other Bp strains from diverse sources (Supplementary 
Table 1) (Welkos et al. 2015; data not shown). Furthermore, 
both Bm FMH and Bp K96243 induced MNGC formation, 
yet Bp was significantly more cytotoxic and the infection 
resulted in ≥90 % killing and loss of adherent cells from 
the monolayer. However, Bm cytotoxicity was observed to 
differ significantly in association with the MOI and was 
generally less for MOIs <5 and more for MOIs >5 in our 
model system. In contrast, the cytotoxicity associated with 
strains of Bp was less affected by the MOI (discussed fur-
ther below). The more extensive cytotoxicity demonstrated 
for K96243 was also observed for other Bp strains from 
diverse sources (Supplementary Table 1) such as 1026b, 
Bp22, and MSHR5848 (Welkos et al. 2015; data not 
shown).
Analysis of in vivo isolates of Burkholderia
The phenotypic characterization strategy was employed to 
examine in vivo isolates of Bm and Bp for changes which 
might be associated with progression of an acute infection 
to a more persistent form. Isolates from spleens collected 
from 3 to 180 days post-challenge from mice involved in 
aerosol or IP LD50 studies were analyzed. Spleen isolates 
obtained from infections by either route were generally 
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observed to be similar in their phenotypic comparisons to 
the corresponding parent challenge strain. Because of the 
in vitro variability of the pathogenic Burkholderia spp., the 
original challenge strain was included in all in vitro assays 
for comparison with the spleen isolates. To categorize 
the in vivo isolates, we empirically defined three phases 
of infection: an acute phase (≤21 days post-challenge), 
a midterm phase (21–59 days), and a long-term phase 
(≥60 days).
Comparison of isolates and parent strains by colony 
morphology phenotyping
Bacteria isolated from mice euthanized during the acute 
phase of infection with either Bm or Bp did not differ sig-
nificantly from the parent challenge strain in their colony 
morphotypes (data not shown). To confirm this observation, 
mice were infected IP with 5 LD50 doses of either strain 
1106a or HBPUB10134a and survivors were serial sampled 
on days 3, 7, or 14 post-infection for spleen colony isola-
tions. These two strains represent mice that were, respec-
tively, the least and most virulent by the intraperitoneal 
route (Welkos et al. 2015). For both strains, the spleen iso-
lates exhibited no significant differences from the challenge 
strain, as typically observed for early stage isolates. Similar 
findings were observed for isolates obtained on days two 
through six after aerosol challenge with HBPUB10134a 
(data not shown).
For spleen isolates from aerosol challenges with the Bm 
FMH strain, there was an apparent increase in the overall 
number of morphotypic differences between spleen iso-
lates and parent with longer times post-challenge. For 
example, most Bm FMH isolates collected ≤day 45 var-
ied little from the parent challenge strain, while isolates 
collected 119 days after challenge were larger on SBAP, 
OFPBL, and BCA plates (data not shown). Similarly, for 
some Bp strains there was an increase in the overall num-
ber of small differences in colony morphology with time 
post-challenge for isolates. For example, isolates of Bp 
strain 1106a collected at times later than day 49 exhibited 
numerous alterations compared to the parent in colony size 
(several media) and morphology (e.g., opacity and moist-
ness). For three Bp strains (1106a, MSHR668, and 406e), 
there was a reduced incidence of multiple colony vari-
ants on SBA, GTA, and/or AA displayed by isolates; i.e., 
whereas the parent exhibited two distinct variants differ-
ing in several characteristics, only one of the variant types 
was observed in all the isolates. This is demonstrated for 
strain 406e in Supplementary Table 5A and B. For some of 
the strains, such as MSHR305 and HBPUB10134a, there 
was a paucity of mice surviving at later time points, and 
among the survivors, few if any had residually infected 
spleens. However, isolates obtained 33 and 35 days post-
infection with MSHR305 were larger on both SBAP and 
AA (day 33) or on SBAP (day 35), and half of those tested 
had enhanced metabolic activity on BCA plates, as indi-
cated by color change in this medium illustrated in Fig. 1d 
(data not shown). Thus, it can be concluded that Bp isolates 
routinely exhibited differences in colony morphology from 
the parent strain, yet an overall common pattern of change 
in isolate colony morphotype was not observed among the 
Bm/Bp strains examined. Therefore, we considered the 
presence of any distinct difference in colony morphotype 
compared to parent colony morphology to be important as 
one of the bases of selecting isolates for subsequent phe-
notypic analyses. Colony morphology differences together 
with GEN III plate differences (described below) were used 
as criteria for selecting strains for subsequent, more com-
plex phenotype assays.
Comparison of isolates and parent strains in antimicrobial 
sensitivities
Spleen isolates were initially screened for sensitivity to 23 
antimicrobial chemicals using GEN III plates, and selected 
isolates were then tested in the additional antimicrobial 
sensitivity assays. All assays included the corresponding 
parental challenge strain for intra-experimental compari-
sons. Isolates obtained from spleens collected between 3 
and 16 days after challenge did not differ significantly in 
sensitivity from the parent Bm FMH or Bp strain. Such iso-
lates included, for example, those from spleens collected 
3 and 16 days after IP challenge with Bm FMH (Fig. 2), 
Fig. 2  Comparison of macrophage survival of Bp and Bm strains. 
The J774.A1 macrophage cell line was infected with Bp strain 
K96243 at a MOI of 4.3; or with Bm strain FMH or its spleen isolates 
Bm 1-1-3 or Bm 1-2-4 at MOIs of 6.8, 7.95, and 7.1, respectively. 
The paired bars correspond to the mean viable counts from triplicate 
wells determined at t0 (macrophage inocula) and after 20-h incuba-
tion of infected macrophages (t20). Spleen isolates Bm 1-1-3 and Bm 
1-2-4 were collected from IP-infected mice on days 3 and 16, respec-
tively
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strains from samples obtained 2–14 days after IP injec-
tion of Bp strains 1106a or HBPUB10134a, and spleens 
collected 2–6 days after aerosol and/or IP exposure to 
HBPUB10134a or 1026b, as described above.
Results with spleen isolates acquired from survivors 
on or after day 26 after aerosol exposure to Bm FMH are 
illustrated in Table 2. These isolates often differed in sen-
sitivity, typically being more resistant than the parent to 
several antimicrobials, especially nalidixic acid and the 
AMPs cecropin A, magainin, and melittin. Isolates from 
the spleens of mice infected with the seven Bp strains 
were obtained from 17 experiments (12 aerosol challenges 
of 7 strains and 5 IP challenges of 5 strains). The results 
of chemical sensitivity screening of the isolates are sum-
marized in Table 3 and Supplementary Table 6. The latter 
details the sensitivity differences between strains for the 
chemicals in Table 3. The data for strain HBPUB10134a 
are not included in these tables since isolates from the 
acute stage of infection were only available (≤day 14). 
The changes in chemical sensitivities of the in vivo isolates 
which are described in Table 3 and Supplementary Table 6 
can be summarized as follows. Differences in sensitivities 
of spleen isolates compared to the Bp parent strain were 
observed most frequently for two antibiotics, nalidixic acid 
and minocycline, for which isolates from five or three of six 
strains tested, respectively, differed in sensitivity from the 
parent strain. Isolates with enhanced resistance to nalidixic 
acid were recovered for all five of the strains. Isolates with 
altered sensitivities compared to the Bp parent strain were 
detected most commonly for four of the chemicals tested 
(Niaproof 4, nitrite, NaCl, and potassium tellurite) and the 
AMPs mastoparan 7, BMAP-18, and magainin. As shown 
in Table 3, overall, these Bp isolates most often exhibited 
an increased resistance to the antimicrobial substances 
compared to the parent. For example, isolates with greater 
resistance to Niaproof 4 were recovered for five of the six 
Bp strains evaluated and isolates with greater resistance to 
NaCl were detected for all three Bp strains from which bac-
teria with altered NaCl sensitivities were obtained. These 
findings can be further illustrated with the isolate sensitiv-
ity results of strains K96243 and 1026b. Supplementary 
Table 3 describes sensitivity patterns of K96243 isolates 
obtained on day 70 after aerosol exposure. Despite paren-
tal strain variability, these isolates were generally enhanced 
Table 3  Summary of 
differences between parent 
B. pseudomallei and in vivo 
isolates in chemical sensitivities
a Spleen isolates from aerosol or IP challenge experiments of seven Bp strains were obtained (17 total 
experiments). The variant responses of the isolates consisted of significant increases in either sensitivity (S) 
or resistance (R) to the antimicrobial chemical compared to the challenge strain, as described in the meth-
ods. The data do not include isolates exhibiting no differences from the parent. For strain HBPUB10134a, 
no isolates were obtained from survivor spleens cultured later than 14 days after challenge, so the data are 
not included in the table
b The sensitivity of isolates collected at early and later time points differed (nalidixic acid, potassium 
tellurite, Niaproof 4, and mastoparan 7) or individual isolates from a given challenge experiment collec-
tion responded differently, being either more sensitive or more resistant than the parent (minocycline, 
Niaproof 4, potassium tellurite, and mastoparan 7) as described in the text
c Different responses by the same isolate were observed in Biolog and antimicrobial sensitivity microtiter 
assays, but chemical concentrations in the Biolog system are proprietary and unavailable
d For one Bp strain each, the sensitivity to the chemical of an isolate(s) varied from that of the parent as 
follows: aztreonam (R), guanidine HCl (R), LL-37 (R), CA-MA (R), and bactenecin (variable)
e Peptides BMAP-18, CA-MA, bactenecin, and LL-37 were tested in four of the six strains only
Chemical No. strains with: variant isolates/total no. strainsa Increased in
Sensitivity Resistance
Niaproof 4 6/6 3b,c 5b,c
Nalidixic acid 5/6 1 5b
Mastoparan 7 4/6 1 4b
BMAP-18 3/4e 0 3
Minocycline 3/6 2 2b
Nitrite 3/6 2 1
NaCl 3/6 0 3
Potassium tellurite 3/6 1b 3b
Magainin 2/6 0 2
Melittin 2/6 1 1
d-Serine 2/6 1 1
Others 1/6d,e – –
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in their resistance to potassium tellurite, Niaproof 4, and 
several AMPs (mastoparan 7 and potentially LL-37, melit-
tin, and BMAP-18) but more sensitive to fusidic acid in 
the GEN III assays. The K96243 isolates were sensitive 
to mastoparan 7 at day 28 and resistant at days 49 and 70 
(Supplementary Table 3 and data not shown), suggesting a 
time-associated response. The responses of the day 30 and 
day 60 isolates from challenge experiments with Bp strain 
1026b are shown in Supplementary Table 4. The data sug-
gested an increase in the resistances of 1026b isolates with 
time post-challenge as seen with nalidixic acid and various 
AMPs such as bactenecin and BMAP-18. These findings 
were intriguing though additional serial kill studies will 
be required to confirm a time-associated pattern of change 
among other Bp strains. It will be necessary to evaluate 
many isolates at each of the time points post-challenge 
from mice. There was no apparent time-associated pattern 
in antimicrobial resistances of the in vivo isolates of strain 
Bm FMH (Table 2).
Comparison of isolates and parent strains in macrophage 
phenotypes
To prospectively evaluate macrophage virulence during the 
acute phase of infection, mice were intraperitoneally chal-
lenged with Bp 1106a and serial killed on days 3, 7, and 14 
post-infection, as described above. The 1106a spleen iso-
lates exhibited a progressive change in macrophage viru-
lence. The day 3 isolate was similar in extent of phagocy-
tosis, survival, and cytotoxicity to the parent, and the day 7 
isolate was phagocytosed to a greater extent but otherwise 
similar in macrophage parameters (data not shown). How-
ever, the day 14 isolate of 1106a (Bp 14-1) was consistently 
more cytotoxic for, and better able to multiply within, mac-
rophages than the parent (data not shown). In addition, Bp 
14-1 was phagocytosed fivefold better, and the 8-h recovery 
of viable cells was more than twice that of the 1106a parent 
(Supplementary Figure 1). The progressive change from 
the parent of in vivo isolates in regard to macrophage viru-
lence may be strain associated. For example, early isolates 
of Bp HBPUB10134a, a strain with more than a three-log 
greater IP virulence than 1106a [4], did not differ signifi-
cantly from the parent in macrophage survival and cytotox-
icity (data not shown).
The macrophage phenotypes of spleen isolates from 
mice with longer term infections were then characterized. 
Bm FMH isolates collected at days 26 and 45 after aero-
sol challenge differed only minimally in cytotoxicity and 
survival compared to the parent. However, day 60 isolates 
were distinctly reduced in survival and/or several cyto-
toxicity parameters, as illustrated in Table 4 and data not 
shown. The cytotoxicity induced by the parent strain was 
dose related in four of five experiments; a relatively low 
MOI produced significant bacterial survival and cell cyto-
toxicity in one experiment for unknown reasons.
In contrast to the results with Bm, the survival and 
cytotoxicity of the isolates in comparison to the Bp par-
ent appeared to be strain dependent. Of the strains of Bp 
from which isolates from long-term infections could be 
recovered, a trend toward enhanced macrophage virulence 
was observed consistently for strains 1106a and MSHR668 
and typically, but less consistently, for K96243. The 
responses of the 1026b isolates were variable, and there 
were usually no differences observed for isolates of par-
ent strain 406e (Fig. 3). Figure 3a shows the results of a 
spleen isolate recovered on day 70 after aerosol exposure 
with strain K96243. Isolate Bp 70-1 was phagocytosed 
to a greater extent compared to K96243 for all three time 
points. Greater cell death and detachment was also asso-
ciated with Bp 70-1 at 8-h (Table 5). The greater cell loss 
associated with Bp 70-1 at 8-h suggests that the 8 h via-
ble counts might have underestimated the strain’s replica-
tion. To account for differences in strain MOIs, the counts 
were normalized to the inoculum (no. CFU added at t0) and 
expressed as percentages. These normalized values, pre-
sented in Supplementary Table 7, confirmed the differences 
shown here. Isolates recovered 49 days post-exposure also 
exhibited better survival than the parent K96243 strain 
(data not shown).
In experiments with strain MSHR668 and two day 41 
isolates, the isolates again replicated better than the chal-
lenge strain (Fig. 3b; Supplementary Table 7); 7–8 h counts 
of the isolates were significantly greater than those of the 
parent. The isolates were more cytotoxic at lower MOIs, 
as shown by the greater proportion of TB-stained dead 
cells and the greater number and larger size of MNGCs 
(Table 5). The cytotoxic effects on macrophages often 
associated with Bp infection are illustrated by MSHR668 
isolate Bp 41-1-infected cells in Fig. 4. The detachment 
of J774.A1 cells and the formation and appearance of 
MNGCs are shown in panels A–B and C–D, respectively. 
Isolates recovered 60 days after IP challenge exhibited sim-
ilar macrophage phenotypes (data not shown). The results 
with strain 1106a and an isolate collected 62 days after 
challenge again exemplified the increase in isolate mac-
rophage infectivity and cytotoxicity, as shown in Fig. 3c. 
Isolate Bp 62-3 was phagocytosed to a greater extent. Both 
strains doubled during the 5-h incubation after removal of 
antibiotic, but the greater loss of macrophages during this 
time in the Bp 62-3-infected culture likely resulted in an 
underestimation of the 8 h viable counts. The isolate was 
more cytotoxic for the macrophages, inducing more cell 
death and detachment from the wells (Table 5).
As shown in Fig. 3d and Table 5, a day 60 isolate from 
strain 1026b was variably more active in macrophages 
than the parent strain, albeit marginally. Although Bp 60-3 
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was phagocytosed to a slightly lesser extent than 1026b 
(1-h and 3-h viable counts), the isolate replicated more 
than twice as fast as the 1026b parent post-phagocytosis, 
as determined by the greater normalized 8-h counts (742 
vs. 1839 % of the inoculum for parent and isolate, respec-
tively; Supplementary Table 7). Isolate Bp 60-3 was also 
slightly more cytotoxic, as shown by the MNGC param-
eters (Table 5 and data not shown). The macrophage 
phenotypes of strain MSHR305 and an isolate collected 
33 days after aerosol challenge (Bp 33-2) suggest the iso-
late was similar to the parent in its capacity to replicate in 
the macrophages and induce a cytotoxic response (Fig. 3e; 
Table 5). Additional day 33 isolates exhibited variable 
macrophage phenotypes (data not shown), perhaps sug-
gesting that persistent infection had not been established. 
Finally, the spleen isolates evaluated from mice challenged 
with Bp strain 406e did not induce macrophage pheno-
types that were consistently different from the challenge 
strain, as determined with spleen isolates from days 34 and 
60 after infection (Fig. 3f; Supplementary Table 7; Table 5; 
and data not shown.
LPS phenotyping
LPS phenotyping was explored as an additional tool for 
distinguishing different strains of Bp and Bm as well as 
their in vivo isolates. Distinct strain-specific differences 
in the LPS banding profiles of numerous other strains of 
each species were distinguished previously (Welkos et al. 
2015). In this study, LPS electrophoretic banding profiles 
of 20 Bp and 13 Bm isolates were compared to those of 
their respective parent strains using species-specific mono-
clonal antibodies for LPS (11G3-1 for Bp and 8G3-1B11 
for Bm). One spleen isolate of Bm FMH obtained on day 60 
post-infection displayed a change in LPS phenotype, from 
smooth to rough, during the course of infection (Fig. 5). 
Table 4  In vitro macrophage-associated phenotypes of isolates from B. mallei-infected animals
NC no change/same response as parent strain
a BALB/c mice were exposed by aerosol to parent strain Bm FMH in an LD50 experiment. Colony isolates were collected from spleens of sur-
viving mice 60 days after exposure. Results are those of two isolates, 60-3 and 60-5, which had differed more from parent in other phenotypes 
(colony morphology and chemical susceptibility) compared to four other isolates. All were from two mice in the lowest aerosol dose group 
(32 CFU). Data are representative of seven experiments. Bolded values are those notably different from parent values
b The bacterial survival is expressed as the change in viable counts after 20–23 h compared to the input inoculum (% of input no. CFU)
c Cytotoxicity was determined after 20–23-h incubation and is shown as the % cells lost [by trypan blue and Diff-Quik™ (DQ) stains]. The 
% dead cells was determined by PI and trypan blue staining. The values do not include cells/MNGCs in an advanced state of necrosis with 
degraded, unstainable DNA
d The values describe approximate proportion of MNGCs among total cells/field and the major relative appearance of nuclei [typical large and 
intact vs. cytotoxic (necrotic/apoptotic or within an MNGC)]
Straina Expt. MOI Bacterial  
survival (%)b
Cytotoxicityc Cell morphologyd
% cell loss (TB, 
DQ)






Bm FMH parent 9 7.7 0.90 >50 ~50 ≥10 % <50/>50 % normal/
cytotoxic
11 2.9 5 × 10−4 <1 1–2 Rare, <1 % >90/<10 % normal/
cytotoxic
12 4.3 ~1 × 10−4 <1 <1 None >90/<10 % normal/
cytotoxic
36 9.6 0.20 ~40 ~65 16.5 37/63 % normal/
cytotoxic
63 2.3 8.80 90 87 20.6 36/64 % normal/
cytotoxic
Isolate 60-5 9 7.9 0.70 NC 12 Rare, <1 % >50/<50 % normal/
cytotoxic
11 2.3 5 × 10−4 NC <1 None NC
12 3.9 <1 × 10−5 NC <1 NC NC
36 8.8 0.25 ~30 ~65 7.10 % 47/53 % normal/
cytotoxic
Isolate 60-3 63 2.2 2.70 50 4 16.8 % 38/62 % normal/
cytotoxic
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Fig. 3  Comparison of macrophage survival of Bp parent strain and 
spleen isolate pairs. J774.A1 cells were incubated with the par-
ent strain or isolate for 1 h. For a–d, f, the data shown are the mean 
viable counts (triplicate wells) recovered after 1-h uptake, after 
incubation of the infected cells in the presence of kanamycin for 
2 h to remove unphagocytosed bacteria (3 h total), and after incuba-
tion for a total of 8 h. a Bp strain K96243 and a mouse spleen iso-
late collected 70 days after exposure (Bp 70-1) with MOIs of 13.3 
and 11.0, respectively. The viable counts determined at the three 
times points were statistically different (1 and 3 h: p < 0.0001; 8 h: 
p = 0.0016). b Bp strain MSHR668 and mouse spleen isolates. The 
MOIs were 38.5 (MSHR668) and 32.3 (Bp 41-1). Each set of bars 
are the data for the challenge strain (MSHR668) and for a spleen 
isolate from a mouse surviving aerosol challenge and euthanized 
on day 41 (Bp 41-1); p = 0.004 for 8 h. Inset macrophages were 
infected with strain MSHR668 or isolates 41-1 or 41-4 at MOIs of 
12.2, 11.2, and 13.1, respectively. The infected cells were incubated 
and treated as described above, and the viable counts obtained after 
a total of 7 h are shown. They are compared to the initial no. of CFU 
added to the wells (t0 inoculum); p < 0.001 for 7 h for 41-1. c Bp 
strain 1106a and a mouse spleen isolate collected 62 days after aero-
sol exposure (Bp 62-3), at MOIs of 12.3 and 14.1, respectively. The 
viable counts of Bp 62-3 determined at the three times points were 
significantly greater than those of 1106a (1 and 3 h: p < 0.0001; 8 h: 
p = 0.013). D. Bp strain 1026b and a spleen isolate from a mouse 
surviving aerosol challenge and euthanized on day 60 (Bp 60-3). The 
MOIs were 9.5 and 11.4, respectively. The viable counts of the parent 
strain were slightly greater than those of the isolate after 1-h incuba-
tion (p = 0.08, not significant) and after 3-h incubation (p = 0.008). 
Greater quantities of isolate than parent were recovered after 8 h 
although the absolute differences were not statistically significant. e 
Macrophages were infected with strain MSHR305 or a spleen isolate 
collected 32 days after exposure (Bp 33-2), at MOIs of 15.4 and 17.5, 
respectively. The infected cells were incubated for 1 h and treated 
with kanamycin for 2 h, and the viable counts obtained after a total of 
7 h are shown. The quantities of bacteria of the two strains recovered 
from the cells at 7 h were not significantly different (1.7 and 2.5 %, 
respectively). f Bp strain 406e and mouse spleen isolate Bp 60-4 at 
MOIs of 17.1 and 15.5, respectively. The viable counts obtained at 
all three time points for the parent and isolate were not significantly 
different (p > 0.05). The observed differences for these experiments 
were confirmed using comparisons of the normalized viable CFU 
counts
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Figure 5a shows a western blot with parent strain FMH, 
a day 60 isolate that did not change its LPS phenotype 
(60-5), and the 60-3 isolate that appeared to change from 
smooth to rough. The transition from a smooth to rough 
LPS phenotype results from the loss of O polysaccharide 
(OPS). This result was further supported by a western blot 
using polyclonal antibody ABE 335 where OPS was absent 
and lipid A was visible, confirming the presence of LPS 
(Fig. 5b). To rule out the possibility that the OPS simply 
changed its structure, thus preventing antibody recognition, 
silver staining was performed (Fig. 5c). No OPS could be 
detected for 60-3 by silver straining, thereby confirming the 
rough phenotype.
Comparison of mouse virulence of Burkholderia strains 
and their spleen isolates
An initial study to compare the virulence and morbid-
ity of strains of Bp and Bm with their in vivo isolates was 
conducted in an established Burkholderia mouse model 
(Welkos et al. 2015). In the current study, BALB/c mice 
were challenged by the IP route with dilutions of a strain 
of Bp/Bm or with a selected spleen isolate. The LD50 
values and relative virulence potencies of parent versus 
isolate were evaluated statistically using the survival data 
accrued by days 21 and 60 (Table 6). Isolates collected 
from midterm survivors did not  always show statistically 
significant differences from their respective parent strains. 
However, the day 60 LD50 of K96243 isolate Bp 49-4 was 
tenfold less, suggesting an enhanced virulence of the iso-
late compared to the parent strain. As for the long-term 
survivors, Bp 60-2 was significantly more virulent than its 
parent strain MSHR668, i.e., its day 21 LD50 was 46-fold 
less than that of the parent strain (Table 6; Fig. 6a). The 
greater virulence of the isolate was also demonstrated by 
its greater potency at all lethal doses up to 90 % mortal-
ity (probability ≤0.9). In Fig. 6b, the lightly shaded area 
indicates the range of lethal doses of Bp 60-2 that were 
associated with significantly greater virulence compared 
to MSHR668. Larger doses of MSHR668 were required to 
produce the same lethality achieved with lower doses of 
isolate. Finally, even  though the day 21 LD50 values of the 
parent Bm FMH strain and isolate Bm 60-5 were similar, 
the day 60 LD50 for isolate Bm 60-5, albeit not statistically 
significant, was almost fourfold less than that of parent 
strain (Table 6).
Table 5  Phenotypes of macrophages infected with B. pseudomallei parent and spleen isolates—cytotoxicity comparisons
nd not done
a Figure 3, panels a–f
b Cytotoxicity is shown as the % cells lost from the macrophage layer by trypan blue (TB) staining and the % dead cells among those remaining 
by TB and/or PI staining. However, necrotic cells and advanced-stage MNGCs with degraded nuclei are unstained by TB, and the values under-
estimate the actual proportion of dead cells
c The values describe the approximate relative proportion of MNGCs (%) among the total cells in six fields, two from each of three replicate 
coverslips (×600); and the major nuclear phenotype, considering all the nucli in the fields (typical large nuclei vs. nuclei present in MNGC with 
intact stained nuclei or in necrotic fused cell masses with lightly stained nuclei), expressed as percentages. Counts were done using Diff-Quik-
stained cells. The more extensive cell death and detachment induced by some strains may minimize the extent of these values
Strain Panela MOI % cell lossb % cells dead (TB)b No. MNGC or necrotic cells (% of total)c No. MNGC nuclei (% of total)c
K96243 a 13.3 40–50 17 4.4 43.6
Bp 70-1 11.0 60–65 32.4 5.8 58.8
MSHR668 b inset
expt. #1 12.2 35–40 4.5 7.6 32.0
Bp 41-1 11.2 60–70 20.0 13.0 54.0
Bp 41-4 13.1 35–40 12.5 14.0 58.0
MSHR668 b
expt. #2 38.5 20 nd 20.7 67.8
Bp 41-1 32.3 18 nd 18.0 73.2
1106a c 12.3 40 27.9 21.9 70.8
Bp 62-3 14.1 60–65 73.2 41.8 85.4
1026b d 9.5 25–30 24 8.8 35.3
Bp 60-3 11.4 25–30 25 9.6 47.4
MSHR305 e 15.4 30 2.5 3.5 10.0
Bp 33-2 17.5 35 2.5 3.5 10.0
406e f 17.1 40 10.3 5.6 21.8
Bp 60-4 15.5 45 22.3 5.0 25.8
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Fig. 4  Changes in the morphology and adherence of macrophages 
infected with Bp. Cells were infected with spleen isolate Bp 41-1 of 
strain MSHR668 and stained with Diff-Quik™ after 7-h incubation. 
The cultures are shown under low power (×100, a, b) and higher 
power (×600, c, d). a Uninfected cells of normal semi-confluent 
J774.A1 cells. b Cells infected with isolate Bp 41-1 showing detach-
ment/loss of cells and presence of numerous multi-nucleated giant 
cells (MNGCs, indicated by arrows) and clusters of fused necrotic 
cells. c, d Cells infected with isolate Bp 41-1 and illustrating the 
appearance of MNGCs with numerous intact nuclei (c) and MNGCs 
in a more advanced state of decay with more necrotic, poorly stained 
nuclei (d)
Fig. 5  LPS phenotyping comparing the Bm FMH parent strain with 
two 60-day mouse spleen isolates. Western blots using monoclonal 
antibody 8G3-1B11 (a) and polyclonal antibody ABE 335 (b) show 
the loss of O polysaccharide in isolate 60-3. This LPS change was 
confirmed by silver staining (c)
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Discussion
A number of in vitro assays were used to identify poten-
tial phenotypic markers for chronic Bp and Bm infection. 
Although a relatively small number of strains were fully 
characterized in vitro and over an extended period in vivo, 
the strains described represented a diversity of Bp from dif-
ferent patient sources and geographical locations to include 
the two foci that have been of predominant research con-
cern: Thailand and Northern Australia. Characterization 
of bacteria isolated during the later stages of a long-term 
infection with Bp or Bm revealed frequent differences in all 
of the characterized phenotypes of the isolates compared to 
the original parent strains. The results of antimicrobial sen-
sitivity assays commonly showed an increase in resistance 
in both Bm and Bp isolates. Whereas there was evidence for 
a positive association between development of increased 
resistance to particular antibiotics, chemicals, and AMPs 
in Bp isolates recovered at early compared to late infection 
times, there was no such trend clearly established with Bm 
isolates. In macrophage assays, infectivity/cytotoxicities 
of Bp isolates from mice with extended infections were 
greater than that of the parent. In contrast, Bm isolates were 
reduced in macrophage replication and cytotoxicity. In LPS 
phenotypic analysis, a potential loss of OPS expression in 
Bm was discovered during the course of infection. Finally, 
preliminary studies in a mouse model suggested that 
enhanced pathogenicity was associated with phenotypic 
variation of isolates from persistent infections.
Many host cells which provide a niche for persistent 
Burkholderia infection also possess activities and antibacte-
rial products (e.g., AMPs and reactive oxygen and nitrogen 
species) important in innate immunity. Thus, intracellular 
pathogens would need to overcome such defenses. In our 
antimicrobial sensitivity assays, differences in the sensitivi-
ties to certain antibiotics, chemicals, and AMPs between 
isolates and parent Bp and Bm strains were often observed. 
Antimicrobial peptides are small cationic molecules which 
are part of the innate host defenses of many organisms. 
These AMPs are not specific for a particular target and their 
bactericidal activity usually involves membrane disruption 
(Andreu and Rivas 1998; Fox et al. 2012; Higashijima et al. 
1988; Kreil 1973; Madhongsa et al. 2013; Skerlavaj et al. 
1996; Steiner et al. 1981; Vila-Farres et al. 2012; Zasloff 
2002, 1987). They are potential therapeutic agents for anti-
biotic-resistant organisms such as Bp and Bm (Kanthawong 
et al. 2009; Kreil 1973; Madhongsa et al. 2013). How-
ever, Burkholderia spp. have been reported to be relatively 
resistant to AMPs, although the sensitivity of Bp appears to 
be strain-specific (Fox et al. 2012; Kanthawong et al. 2009; 
Tandhavanant et al. 2010). For instance, notable sensitivity 
of Bp to the human cathelicidin peptide LL-37, or to hybrid 
Table 6  Statistical comparison 
of relative virulence for mice of 
Burkholderia strains and their 
in vivo isolates
a BALB/c mice were challenged by the IP route with a strain of Bp or Bm, or a spleen isolate of the strain, 
and the mice were monitored for morbidity and mortality for 60 days. The 21- and 60-day survival data 
were analyzed for each strain, and the data were evaluated statistically to compare parent strain and spleen 
derivative relative virulence potencies and LD50 values (no. CFU) by using Bayesian probit analysis, as 
described in the methods. The bolded LD50 values are those which were significantly different from the 
parent strain LD50 value
b The day 21 LD50 value of Bp 60-2 was less than that of parent strain MSHR668 (probability ≥95 %) and 
the isolate exhibited greater potency at all lethal doses up to 90 % (probability of mortality ≤0.9)
c The day 21 LD50 values of K96243 and its isolate Bp 49-4 were not significantly different. The day 60 
LD50 of the isolate was about tenfold less than that of the parent, although not significantly different
d Although the day 60 LD50 for isolate Bm 60-5 was almost fourfold less than that of the parent strain, the 
values were not significantly different
Strain Day 21a Day 60a
LD50 95 % credible interval LD50 95 % credible interval
Lower Upper Lower Upper
Bp MSHR668 3.9 × 102 1.7 × 102 8.6 × 102 0.3 0 1.6 × 101
Bp 41-1 4.7 × 102 1.2 × 102 2.2 × 103 5.1 0.1 3.8 × 101
Bp 60-2 8.4b 0.7 4.3 × 101 3.4 0.5 1.2 × 101
Bp K96243 2.3 × 104 1.2 × 104 4.7 × 104 1.9 × 103 4.7 × 102 6.1 × 103
Bp 49-4 4.3 × 104 2.3 × 104 7.7 × 104 1.9 × 102c 0.4 2.2 × 103
Bp 1106a 3.3 × 104 1.7 × 104 6.4 × 104 1.2 × 104 3.3 × 103 4.0 × 104
Bp 62-3 4.7 × 104 1.9 × 104 1.2 × 105 1.2 × 104 7.0 × 103 2.0 × 104
Bm FMH 3.3 × 107 1.4 × 107 7.6 × 107 1.1 × 107 2.1 × 106 7.2 × 107
Bm 60-5 2.1 × 107 1.2 × 107 3.7 × 107 2.9 × 106d 7.7 × 105 1.2 × 107
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peptides containing this AMP, has been observed (Fox et al. 
2012; Kanthawong et al. 2009; Tandhavanant et al. 2010). 
Although the Bp and Bm strains used in this study were 
overall relatively resistant to AMPs, they were often more 
sensitive to some AMPs than were their spleen isolates 
(i.e., For mastoparan 7, BMAP-18, and magainin). There-
fore, altered sensitivities of isolates to certain AMPs, such 
as mastoparan 7 and BMAP-18, could potentially be used 
as candidate markers for screening isolates from persistent 
Burkholderia infections. Nonetheless, and as expected, 
increased isolate resistance to specific AMPs was strain 
dependent, as demonstrated for 1026b and K96243.
Intracellular Bp has also been shown to evade or sup-
press production of reactive oxygen and nitrogen species, 
as well as other harsh chemicals (Chantratita et al. 2007; 
Dowling et al. 2010; Loprasert et al. 2003; Mulye et al. 
2014; Tandhavanant et al. 2010; Utaisincharoen et al. 2001, 
2004). In our study, Bp spleen isolates from three strains 
harbored sensitivities to sodium nitrite that differed from 
the parent. But whereas isolates of one strain were more 
resistant than the parent, those from two strains exhibited 
increased sensitivity. However, for most chemicals, the 
in vivo isolates displayed phenotypes of enhanced resist-
ance, as exemplified by the responses to elevated NaCl 
concentrations, potassium tellurite, and variably to the sur-
factant Niaproof 4. Detergents such as Niaproof 4 often 
have opsonophagocytic activity and may play a role in 
innate immunity (Wright 1997, 2003). A direct association 
between time post-challenge and the number or extent of 
sensitivity differences exhibited by isolates was not always 
apparent but was suggested for not only several AMPs, 
but also the antibiotic nalidixic acid and potentially for 
Niaproof 4 and potassium tellurite, as described above. The 
isolate response data en toto suggested that extended main-
tenance of Bp in vivo may be facilitated by development of 
an increased resistance to antibacterial environments such 
as the macrophage phagolysosome.
As illustrated by our findings, the identification of infec-
tion-associated in vitro phenotypes is influenced by the phe-
notypic variability of the Burkholderia, and especially Bp, 
which is often associated with reversible epigenetic altera-
tions (Chantratita et al. 2007, 2012; Velapatino et al. 2012; 
Vipond et al. 2013). The ability of Bp to produce different 
colony morphotypes is well known (Nicholls and Cantab 
1930; Rogul and Carr 1972; Stanton et al. 1924) and poten-
tially reflects adaptive changes that enhance fitness in a par-
ticular environment. Chantratita et al. (2007) observed that 
different Bp colony morphologies could be recovered from 
individual sites in patients with melioidosis. They identi-
fied and characterized seven colony morphologies. Type I 
could switch to the other six types in apparent response to 
environmental stresses such as iron limitation (Chantratita 
et al. 2007). Morphotypes I, II, and III were associated with 
differential ability to survive and persist in cell culture and 
mice and with resistance to peroxide and AMPs (Chan-
tratita et al. 2007; Tandhavanant et al. 2010). Morphotypes 
associated with adaptive fitness differed significantly in 
the expression profiles of up- and down-regulated proteins 
(Chantratita et al. 2012). However, the finding that specific 
colony morphotypes are predictive of enhanced resist-
ance to certain stresses may be strain related. Analyses of 
additional Bp strains revealed heterogeneity in responses 
between and within strains (Chantratita et al. 2007; Tand-
havanant et al. 2010), and further analyses may be needed 
to confirm associations between in vitro phenotype differ-
ences and in vivo survival and persistence. More recently, 
Wikraiphat et al. (2015) described mucoid (M) and nonmu-
coid (NM) variants from the same sample which exhibited 
Fig. 6  Comparison of relative virulence for mice of Bp strain 
MSHR668 and spleen isolate Bp 60-2 collected on day 60 after infec-
tion. a Mice were challenged by the IP route with different doses of 
the bacteria, and the daily morbidity/mortality data through day 60 
were used to determine the strain LD50 values. The isolate LD50 was 
significantly less than that of the parent (Table 6). b Statistical pair-
wise comparisons of relative potency of MSHR668 and its isolate at 
each lethality level along the dose–survival curve
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antigenically different OPS. The association between col-
ony type switching and conformational differences in OPS 
was determined in analysis of several M/NM pairs from 
clinical samples under different in vitro growth conditions. 
Although the mechanism regulating colony/OPS variation 
and differential growth fitness is not entirely clear, the asso-
ciation between colony type and OPS modification might 
be the basis of the colony variation described previously 
(Nicholls and Cantab 1930; Srinivasan et al. 2001). As 
reported by Austin et al. (2015), Bp strain K96243 exhib-
ited three colony variants which differed not only in col-
ony morphology but also in other in vitro phenotypes. The 
isogenic colony types (one white and two yellow forms) 
were relatively stable but reversible, and they grew differ-
entially in vitro under low oxygen or acidic environments. 
Only one type, albeit highly attenuated, could persist in 
the harsh conditions of the murine stomach and colonize 
the mucosa. A transcriptional regulator controlling colony 
variation was identified, though it is unknown whether this 
gene or a global master regulator controls this as well as 
other examples of reversible phenotypic switching in Bp. 
Lastly, Velapatino et al. (2012) analyzed proteins from 
Bp isolates recovered from a patient during the acute and 
relapse stages of infection. Colony Morphotype I (Chan-
tratita et al. 2007; Wikraiphat et al. 2015) was recovered 
from the primary infection and an additional morphotype 
(III) was recovered during the relapse phase. Many proteins 
were differentially regulated for the relapse isolate com-
pared to acute stage isolates, e.g., enhanced production of 
factors which detoxify the damaging RNI nitric oxide and 
proteins required for anaerobic growth. Prospective studies 
with Bp strains harboring mutations in relevant differen-
tially expressed genes are needed to link expression with 
in vivo persistence. Strains of Burkholderia species other 
than Bp are also known to exhibit phenotypic variability. 
Romero et al. (2006) showed that in vitro passaging of Bm 
strains originally obtained from animal or human sources 
produces a diverse population of clones with alterations in 
mRNA levels of many genes. The changes in phenotypic 
expression were associated with insertions or deletions in 
DNA repeat regions which occurred rapidly. Such events 
may contribute to the instability of the Bm genome and 
enhance bacterial fitness. They might also partially explain 
the variability observed in this and other studies between 
and within Bp and Bm strains in colony morphology and in 
response to antimicrobial compounds (Austin et al. 2015; 
Chantratita et al. 2007; Tandhavanant et al. 2010; Velapa-
tino et al. 2012; Wikraiphat et al. 2015). Members of the 
Burkholderia cepacia complex (BCC) exhibit colony mor-
phology switching associated with their ability to colonize 
the lungs and cause severe infection in patients with cystic 
fibrosis (Bernier et al. 2008; Vial et al. 2010). For instance, 
phase switching by B. ambifaria resulted in alterations in 
colony morphology, biofilm formation, plant root coloniza-
tion, and virulence. The data suggested that B. ambifaria 
adapts to the very different environments of patient lungs 
and the rhizosphere by reversible phase variation.
Phagocytic components of the cellular immune system 
are known to have a dual role in infection. They can serve 
both as critical components of host immune protection 
against Burkholderia infection and as facilitators of bacte-
rial persistence in vivo (Galyov et al. 2010; Gregory and 
Waag 2008; Mulye et al. 2014; Valvano et al. 2005). For 
instance, depleting mice of macrophages has been shown to 
increase their susceptibility to melioidosis (Breitbach et al. 
2006), and inducible nitrous acid synthase was essential 
for clearance of Bm from macrophages (Brett et al. 2008). 
These results suggest a role for macrophages in host pro-
tection. However, Bp and Bm produce virulence factors 
(secreted proteins of the T3SS and T6SS-1, BimA, and oth-
ers) which allow the bacteria to escape the phagolysosome, 
multiply in the cytoplasm, and spread by direct cell-to-cell 
passage (Brett et al. 1994; Chuaygud et al. 2008; Dowling 
et al. 2010; Galyov et al. 2010; Gregory and Waag 2008; 
Kespichayawattana et al. 2000; Stevens et al. 2005a, b; 
Utaisincharoen et al. 2004; Valvano et al. 2005; Whitlock 
et al. 2008, 2009). Thus, the expression of numerous viru-
lence factors which promote bacterial survival and inhibit 
cellular antibacterial mechanisms may contribute to the 
persistence of these agents in a relatively sheltered intracel-
lular host niche (Butt et al. 2014).
Several studies have highlighted genetic and phenotypic 
characteristics potentially associated with persistence of Bp 
and Bm (Hayden et al. 2012; Price et al. 2013; Velapatino 
et al. 2012). Hayden et al. compared genome sequences 
of Bp strain pairs from patients consisting of the primary 
infecting strain and an isolate from relapsed infection 
occurring long after a successful response to antibiotic 
treatment (Hayden et al. 2012). They observed numerous 
genetic changes (indels, SNPs, and structural variations) 
for all the primary-relapse pairs. The only consistent altera-
tion was in a homolog of the TetR family of global tran-
scriptional regulators. At least one of the relapse isolates 
exhibited much higher MICs to several antibiotics relative 
to the primary strain. Their studies supported the hypoth-
esis that this homolog and similar genes play a role in Bp 
adaptive survival in vivo. In studies with Bm, Romero et al. 
reported extensive genomic variability and rapid altera-
tions in RNA expression in isolates obtained after passage 
in animal and human subjects (Romero et al. 2006). Price 
et al. also found significant genomic changes in Bp strains 
isolated almost 12 years apart from a chronically infected 
human survivor (Price et al. 2013). These changes appeared 
to mark an adaptive evolution that occurred over time and 
included inactivation of major virulence factor and regu-
latory genes required for environmental survival. This 
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apparent reductive evolution appeared to mimic the process 
thought to have led to the genomic losses and conversion of 
Bm from a free-living microbe such as Bp into an obligate 
host pathogen.
In this study, although isolates of Bm FMH obtained 
early after infection displayed variable macrophage cyto-
toxicity and survival, most collected on day 60 were clearly 
reduced in both toxicity and intracellular growth. The basis 
for the attenuated phenotype is not known, but it conceiv-
ably reflects a shift in the infection toward a more chronic 
or subclinical intracellular form less prone to stimulate 
host immune responses. In contrast, of the five Bp strains 
for which colonies from mid- to long-term infections were 
available, isolates from three (MSHR668, 1106a, and less 
consistently, K96243) were more virulent for macrophages 
than the parent strain in their ability to multiply within or 
produce cytotoxic responses. However, the other Bp strains 
were more variable so the significance of the relationship 
between macrophage phenotypes and mouse virulence 
requires further study. It must be noted that macrophage 
cultures cannot replace or fully model pathogenesis, and 
animal models are needed for preliminary confirmation 
of significant findings obtained from cell culture. Further-
more, results using macrophage models may differ depend-
ing on the source of macrophage used and other factors. 
Whereas the results shown here and those of various other 
investigators employed murine-derived macrophage-like 
J774.A1 cells (Chantratita et al. 2007, 2012; Haussler et al. 
2003; Kespichayawattana et al. 2000; Stevens et al. 2003; 
Tandhavanant et al. 2010; Wand et al. 2011; Welkos et al. 
2015), others used cell lines such as murine RAW264.7 
cells or human monocyte-like U937 cells (Arjcharoen 
et al. 2007; Brett et al. 2008; Burtnick et al. 2010, 2011; 
Chantratita et al. 2012; Pegoraro et al. 2014; Stevens et al. 
2002; Tandhavanant et al. 2010; Utaisincharoen et al. 2000, 
2004). Overall, we observed relatively reduced survival of 
Bm in J774.A1 macrophages compared to that of Bp, as 
reported previously (Brett et al. 2008). However, Bm gener-
ally appeared to be capable of greater J774.A1 macrophage 
survival and extensive cytotoxic activity at higher MOIs, 
yet these attributes were negatively impacted at higher 
MOIs in studies using a RAW264.7 model (Brett et al. 
2008). The source of the macrophages and differences in 
model parameters likely explain some of the differences in 
results. Macrophage models are important tools in patho-
genesis research with the caveat that they likely provide 
a model which is restricted to specific defined aspects of 
infection.
LPS differences can also be used as phenotypic mark-
ers, and previous studies suggest that Burkholderia LPS 
changes could be associated with chronic infection (Evans 
et al. 1999; Price et al. 2013). In this study, we provide evi-
dence that Bm has the ability to lose OPS during the course 
of infection. This is intriguing because OPS modification 
and loss has been established as a hallmark of chronic 
Pseudomonas aeruginosa infection (Smith et al. 2006). 
In addition, rough Burkholderia cepacia strains lacking 
OPS have been associated with chronic infection in the 
lungs of cystic fibrosis patients (Evans et al. 1999). There 
are many possible reasons why losing OPS could benefit 
Burkholderia during infection. P. aeruginosa and Salmo-
nella typhimurium mutants lacking OPS have been shown 
to increase outer membrane vesicle (OMV) formation 
(Salkinoja-Salonen and Nurmiaho 1978; Smit et al. 1975). 
OMVs are important virulence factor delivery mechanisms 
used by a wide variety of bacterial pathogens and can help 
the bacteria disseminate throughout the body (Kuehn and 
Kesty 2005). OMVs are also secreted by S. typhimurium 
when grown intracellularly (Garcia-del Portillo et al. 1997). 
In addition, once inside the macrophage, the bacteria may 
no longer have a need for OPS. Bp and Bm OPS has been 
shown to play a role in serum resistance (Brett et al. 2007; 
DeShazer et al. 1998). However, a mutation that disrupts 
OPS synthesis may not have a negative effect on bacterial 
survival once inside the macrophage because the bacte-
ria are protected from serum. The loss of OPS could also 
play a role in evading the host immune response during 
relapse of an infection. OPS is highly immunogenic, and 
antibodies are produced by the host to recognize OPS 
from specific bacterial species, including Bp and Bm (Ho 
et al. 1997; Trevino et al. 2006). The loss of OPS could be 
highly advantageous during relapse of infection when the 
bacteria exit the macrophage, as the immune system would 
have a delayed response in recognizing the bacteria. Due 
to these possible implications, it is clear that the potential 
role of OPS in Burkholderia chronic infection warrants fur-
ther investigation. Future studies include sequencing the 
OPS biosynthetic gene cluster of Bm FMH 60-3 to iden-
tify the genetic basis for the loss of OPS. In addition, the 
LPS of isolates from more well-established chronic Bp and 
Bm mouse models will be examined to look for additional 
instances of LPS changes during the course of infection. 
Rough isolates/strains will also be passaged through mice 
to determine the effect of OPS loss on virulence.
In initial attempts to detect a relationship between 
altered phenotypes and pathogenicity, the mouse virulence 
of Bp/Bm strains and their respective isolates was com-
pared. The challenge data for three strains and their in vivo 
isolates suggested that bacteria isolated from persistently 
infected animals can differ significantly from the original 
strain in virulence, as indicated by LD50 and lethal dose 
potency comparisons. This was clearly demonstrated with 
one isolate (MSHR668 isolate 60-2) and potentially for the 
isolates of Bp strain K96243 and Bm strain FMH. Taken 
together, the data suggest that some isolates from mice per-
sistently infected with certain Burkholderia strains might 
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be enhanced in virulence compared to the parent and that 
this enhanced pathogenicity was associated with pheno-
typic variation. It was interesting that isolates of two of the 
three Bp strains (MSHR668 and K96243), with a tendency 
for enhanced survival and cytotoxicity for macrophages, 
were also more virulent for mice. The inverse was observed 
for the day 60 Bm isolate 60-5 which was more virulent 
for mice but, as shown also for Bm isolate 60-3, prolifer-
ated less and/or was less cytotoxic for macrophages. Per-
haps the different results of Bp and Bm in vivo isolates in 
macrophages are associated with the lesser ability of Bm to 
destroy the host cell (and lose an in vivo niche) compared 
to Bp in the J774.A1 macrophage model. Further investiga-
tions are obviously needed. However, it may be possible to 
take advantage of several of the measurable aspects of the 
bacterial-macrophage interaction to show that a significant 
change (increase/reduction) in a parameter of infection, 
such as a change in the proportion of MNGCs, represents a 
potential marker to signal a conversion of a relatively acute 
to more persistent stage in the pathogenesis of infection.
It is not unexpected that the virulence of the in vivo iso-
lates often appeared to be enhanced compared to that of the 
parent strain. The laboratory culture of pathogenic bacte-
rial strains has been shown to result in the accumulation of 
genetic changes and thus genetically mixed cultures which 
can impact virulence. Genomic plasticity and instability 
has been extensively characterized not only for Bp and Bm 
but also for Yersinia pestis (Buchrieser et al. 1998; Galyov 
et al. 2010; Perry and Fetherston 1997; Romero et al. 
2006; Sahl et al. 2015; Tumapa et al. 2008). The passage 
of nonuniform cultures of some pathogens such as Y. pes-
tis and Legionella pneumophila in vivo selects for the most 
fit clones and has been used to increase genetic uniformity 
and restore virulence (Bozue et al. 2011; Cirillo et al. 1999; 
Welkos et al. 1997). This has also been shown or suggested 
more recently for Bp and Bm (Chen et al. 2014; Inglis et al. 
2000; Waag and DeShazer 2004). However, the Burkholde-
ria appear to exploit their capacity for genomic variabil-
ity by generating diverse populations which accumulate 
in vivo in response to differing host environments (Price 
et al. 2010, 2013; Romero et al. 2006). Thus, the impact of 
in vivo passage on the Burkholderia could be complex and 
strain or host dependent.
Overall, this study has identified potentially useful and 
often specific phenotypic markers of long-term Burkholde-
ria infection in several different phenotypic classes (mor-
photype, antimicrobial sensitivities, macrophage infection, 
LPS, and murine virulence). Additional studies are needed 
to confirm the consistency and range of these pheno-
types in chronic infection models and examine the poten-
tial role for them in establishment of a chronic infection. 
However, in vivo residence was clearly associated with 
changes in resistance and responses to many potential host 
antibacterial defenses. The wide diversity of the antibacte-
rial chemicals and other stressors impacted by these altered 
Bp responses suggests that the host environmental factors 
and/or bacterial switch mechanisms driving a conversion to 
resistance are multifactorial.
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